NM_198173.3:c.1451A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198173.3(GRHL3):​c.1451A>G​(p.Asn484Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0397 in 1,613,150 control chromosomes in the GnomAD database, including 1,470 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.033 ( 104 hom., cov: 31)
Exomes 𝑓: 0.040 ( 1366 hom. )

Consequence

GRHL3
NM_198173.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.114

Publications

9 publications found
Variant links:
Genes affected
GRHL3 (HGNC:25839): (grainyhead like transcription factor 3) This gene encodes a member of the grainyhead family of transcription factors. The encoded protein may function as a transcription factor during development, and has been shown to stimulate migration of endothelial cells. Multiple transcript variants encoding distinct isoforms have been identified for this gene.[provided by RefSeq, Aug 2010]
GRHL3 Gene-Disease associations (from GenCC):
  • van der Woude syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • van der Woude syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019854307).
BP6
Variant 1-24344928-A-G is Benign according to our data. Variant chr1-24344928-A-G is described in ClinVar as Benign. ClinVar VariationId is 465249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0329 (4995/151784) while in subpopulation NFE AF = 0.0473 (3209/67866). AF 95% confidence interval is 0.0459. There are 104 homozygotes in GnomAd4. There are 2455 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 4995 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRHL3NM_198173.3 linkc.1451A>G p.Asn484Ser missense_variant Exon 12 of 16 ENST00000361548.9 NP_937816.1 Q8TE85-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRHL3ENST00000361548.9 linkc.1451A>G p.Asn484Ser missense_variant Exon 12 of 16 1 NM_198173.3 ENSP00000354943.5 Q8TE85-5

Frequencies

GnomAD3 genomes
AF:
0.0329
AC:
4992
AN:
151666
Hom.:
104
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00779
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0299
Gnomad ASJ
AF:
0.0294
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00892
Gnomad FIN
AF:
0.0738
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0473
Gnomad OTH
AF:
0.0330
GnomAD2 exomes
AF:
0.0335
AC:
8420
AN:
251056
AF XY:
0.0334
show subpopulations
Gnomad AFR exome
AF:
0.00764
Gnomad AMR exome
AF:
0.0223
Gnomad ASJ exome
AF:
0.0367
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0674
Gnomad NFE exome
AF:
0.0454
Gnomad OTH exome
AF:
0.0382
GnomAD4 exome
AF:
0.0404
AC:
59041
AN:
1461366
Hom.:
1366
Cov.:
33
AF XY:
0.0396
AC XY:
28823
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.00627
AC:
210
AN:
33470
American (AMR)
AF:
0.0230
AC:
1027
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0357
AC:
931
AN:
26092
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0108
AC:
929
AN:
86254
European-Finnish (FIN)
AF:
0.0717
AC:
3831
AN:
53394
Middle Eastern (MID)
AF:
0.0319
AC:
184
AN:
5760
European-Non Finnish (NFE)
AF:
0.0448
AC:
49769
AN:
1111632
Other (OTH)
AF:
0.0357
AC:
2158
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2863
5726
8589
11452
14315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1760
3520
5280
7040
8800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0329
AC:
4995
AN:
151784
Hom.:
104
Cov.:
31
AF XY:
0.0331
AC XY:
2455
AN XY:
74168
show subpopulations
African (AFR)
AF:
0.00777
AC:
321
AN:
41336
American (AMR)
AF:
0.0298
AC:
455
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.0294
AC:
102
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00914
AC:
44
AN:
4814
European-Finnish (FIN)
AF:
0.0738
AC:
778
AN:
10542
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0473
AC:
3209
AN:
67866
Other (OTH)
AF:
0.0327
AC:
69
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
225
450
676
901
1126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0391
Hom.:
240
Bravo
AF:
0.0287
TwinsUK
AF:
0.0502
AC:
186
ALSPAC
AF:
0.0490
AC:
189
ESP6500AA
AF:
0.00908
AC:
40
ESP6500EA
AF:
0.0460
AC:
396
ExAC
AF:
0.0324
AC:
3932
Asia WGS
AF:
0.00578
AC:
20
AN:
3476
EpiCase
AF:
0.0450
EpiControl
AF:
0.0442

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

GRHL3-related disorder Benign:1
Aug 08, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Van der Woude syndrome 2 Benign:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.3
DANN
Benign
0.85
DEOGEN2
Benign
0.12
.;T;.;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.73
T;T;T;T
MetaRNN
Benign
0.0020
T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.0
L;L;.;.
PhyloP100
0.11
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.030
N;N;N;N
REVEL
Benign
0.025
Sift
Benign
0.68
T;T;T;T
Sift4G
Benign
0.79
T;T;T;T
Polyphen
0.0010
.;.;.;B
Vest4
0.21
MPC
0.29
ClinPred
0.0011
T
GERP RS
-0.14
Varity_R
0.028
gMVP
0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116396279; hg19: chr1-24671418; COSMIC: COSV108035898; COSMIC: COSV108035898; API